AC Immune SA (ACIU) is a pharmaceutical preparations company incorporated in Switzerland, listed on the Nasdaq. With a market capitalization of $295 million, AC Immune SA is a micro-cap company. The stock currently trades at $2.88, down 1.88% today, with a 52-week range of $1.43–$4.00.
No 10-K filings found.